Mazor Robotics Announces the Election of Yuval Yanai to its Board of Directors
November 29 2016 - 6:00AM
Business Wire
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and
a leader in the field of surgical guidance systems, today announced
that Mr. Yuval Yanai, a medical device industry veteran, has been
elected to the Company’s Board of Directors, effective
immediately.
Mr. Yanai is a senior executive, who brings over 30 years of
experience to Mazor. Currently Mr. Yanai serves as a Director in
two publicly-traded companies listed on NASDAQ Global Market,
Macrocure Ltd. and Check-Cap Ltd. Mr. Yanai also serves as a
Director in two publicly traded companies listed on the Tel Aviv
Stock Exchange, Medical Compression Systems (D.B.N) Ltd. and Clal
Biotechnology Industries Ltd. In addition, Mr. Yanai serves as a
Director of Haddasah Medical Center, Standard & Poors Maalot,
Compulab Ltd. and Efranat Ltd. Mr. Yanai also acts as the Chairman
of Endobetix Ltd. and the Israeli Fund for UNICEF. From 2005
through 2014, Mr. Yanai held the positions of Senior Vice President
and Chief Financial Officer of Given Imaging Ltd., a developer and
manufacturer of diagnostic products for the visualization and
detection of disorders of the gastrointestinal tract. Given Imaging
Ltd. was sold to Covidien Ltd. for $1 billion in 2014. Mr. Yanai
holds a B.Sc. degree in Accounting and Economics from Tel-Aviv
University.
"I am pleased to welcome Yuval to Mazor’s Board of Directors.
His experience with industry and publicly-traded companies enhances
our Board of Directors as we seek to further leverage two key
recent accomplishments – the strategic agreements signed in May
with Medtronic and the successful October launch of the Mazor X
system,” commented Jonathan Adereth, Chairman of Mazor’s Board of
Directors.
“Mazor’s performance and commitment to innovation have
contributed to its position as the market leader in guidance
systems for spine surgeries. I am looking forward to working with
the Board and being part of Mazor’s continued success,” commented
Mr. Yanai.
About Mazor
Mazor Robotics (TASE: MZOR; NASDAQGM: MZOR) believes in healing
through innovation by developing and introducing revolutionary
technologies and products aimed at redefining the gold standard of
quality care. Mazor Robotics Guidance Systems enable surgeons to
conduct spine and brain procedures in a precise manner. For more
information, please visit http://www.MazorRobotics.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
and other securities laws. For example, we use forward-looking
statements when we discuss our plan to further leverage our two key
accomplishments – the Medtronic agreement and the overwhelmingly
positive response to the Mazor X launch, and when we discuss our
mission to continue to transform and redefine the standard of care
for spine surgeries. These statements are only predictions based on
Mazor’s current expectations and projections about future events.
There are important factors that could cause Mazor’s actual
results, level of activity, performance or achievements to differ
materially from the results, level of activity, performance or
achievements expressed or implied by the forward-looking
statements. Those factors include, but are not limited to, the
impact of general economic conditions, competitive products,
product demand and market acceptance risks, reliance on key
strategic alliances, fluctuations in operating results, and other
factors indicated in Mazor’s filings with the Securities and
Exchange Commission (SEC) including those discussed under the
heading “Risk Factors” in Mazor’s annual report on Form 20-F filed
with the SEC on May 2, 2016 and in subsequent filings with the SEC.
For more details, refer to Mazor’s SEC filings. Mazor undertakes no
obligation to update forward-looking statements to reflect
subsequent occurring events or circumstances, or to changes in our
expectations, except as may be required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161129005325/en/
U.S. Contacts:EVC GroupInvestorsMichael Polyviou,
212-850-6020mpolyviou@evcgroup.comorDoug Sherk,
646-445-4800dsherk@evcgroup.com
Mazor Robotics (NASDAQ:MZOR)
Historical Stock Chart
From Jan 2025 to Feb 2025
Mazor Robotics (NASDAQ:MZOR)
Historical Stock Chart
From Feb 2024 to Feb 2025